About Pudee

Reliability, Responsibility and Rapidity

Founded in 2007, focus on the synthesis of small molecule compounds and the extraction of some natural compounds. We develop, produce and sell high-quality advanced intermediates and some APIs with competitive prices.
Get Appointment

Contact Info

  • Building 2, Handa Science and Technology Park
    No. 8 Pioneer Road
    High-tech Zone. Suzhou.
  • 86 512 6803 2792
    86 512 6803 2791
  • willdyhan@pudeepharm.com
    sales@pudeepharm.com

Product List

115522-15-1, 3,5-Dihydroxy-1-adamantyl methacrylate,photoresist material
115522-15-1, 3,5-Dihydroxy-1-adamantyl methacrylate,…… | 115522-15-1
Suzhou Pudee is a small and below-the-radar company that has been engaged in the research and development of advanced single molecules for nearly tw……
171417-91-7,Naphthalimidyltrifluromethan sulfornate
171417-91-7,Naphthalimidyltrifluromethan sulfornate | 171417-91-7
Suzhou Pudee is a small and below-the-radar company that has been engaged in the research and development of advanced single molecules for nearly tw……
230299-17-9,Bis[(-)-pinanediolato]diboron
230299-17-9,Bis[(-)-pinanediolato]diboron | 230299-17-9
Suzhou Pudee is a small and below-the-radar company that has been engaged in the research and development of advanced single molecules for nearly tw……
230299-05-5,Bis[(+)-pinanediolato]diboron
230299-05-5,Bis[(+)-pinanediolato]diboron | 230299-05-5
Suzhou Pudee is a small and below-the-radar company that has been engaged in the research and development of advanced single molecules for nearly tw……
Enasidenib
Enasidenib | 1446502-11-9
Enasidenib is an inhibitor of IDH2. It is a drug used to treat relapsed or refractory acute myeloid leukemia in people with specific mutations of th……
Enasidenib Intermediate,1446507-38-5
Enasidenib Intermediate,1446507-38-5 | 1446507-38-5
Enasidenib is an inhibitor of IDH2. It is a drug used to treat relapsed or refractory acute myeloid leukemia in people with specific mutations of th……
Fostamatinib disodium
Fostamatinib disodium | 1025687-58-4
" Fostamatinib is an experimental drug candidate for the treatment of a variety of diseases, originally developed by Rigel Pharmaceuticals. The drug……
Fostamatinib intermediate 1
Fostamatinib intermediate 1 | 901119-38-8
" Fostamatinib is an experimental drug candidate for the treatment of a variety of diseases, originally developed by Rigel Pharmaceuticals. The drug……
Fostamatinib intermediate 2
Fostamatinib intermediate 2 | 841290-80-0
" Fostamatinib is an experimental drug candidate for the treatment of a variety of diseases, originally developed by Rigel Pharmaceuticals. The drug……